Delivery Order SPE2DB22D6029-SPE2DB25FLVED
- Not listed
- The Defense Logistics Agency awarded a $25,840.56 delivery order to AmerisourceBergen Drug Corp for 28-count units of Revlimid 10 mg capsules under a firm fixed price contract. The award was made on July 14, 2025, with an ultimate completion date of August 4, 2025. AmerisourceBergen will perform the contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award with no set-aside designation, reflecting the contractor's capability to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $105,150.98 for Revlimid 10 mg capsules (100-count units) on August 20, 2025, with an ultimate completion date of September 11, 2025. This is a firm fixed price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $147,872 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Revlimid 10 mg capsules (28-count packages). This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Revlimid 25 mg capsules (100-count units) under a firm fixed-price contract valued at $52,487.80, with completion expected by September 26, 2025. This non-competitive delivery order represents a continuation of the company's critical role as a pharmaceutical supplier to the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency has awarded a delivery order valued at $48,095.44 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count packages). This firm fixed-price, competitively awarded delivery order is scheduled for completion by October 20, 2025, with the product being delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $24,658.32 to AmerisourceBergen Drug Corp for 28-count bottles of Revlimid 5 mg capsules under a firm fixed price contract. The award was made on July 14, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $25,840.56 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) under a firm fixed price contract. The award, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and will fulfill...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Revlimid 25 mg capsules (100 count) with a ceiling value of $104,975.62. This firm fixed-price delivery order, which is expected to be completed by October 15, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $12,920.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (quantity: 28 count) on October 8, 2025, with an ultimate completion date of October 30, 2025. This non-set-aside contract was competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $52,487.80 by the Defense Logistics Agency for the supply of Revlimid 25 mg capsules (100-count units). The award, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. This contract was competitively awarded and will be performed at the...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVEDDelivery Order
The Defense Logistics Agency awarded a $37,445.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for 21-count packages of Revlimid 15 mg capsules, with an ultimate completion date of June 24, 2025. This non-set-aside competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX that extends through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense and veteran healthcare systems. As a child delivery order under the SPE2DX IDC, this award represents a discrete fulfillment of pharmaceutical inventory requirements supporting military healthcare operations. AmerisourceBergen's DLA contract portfolio encompasses a comprehensive range of medications and medical supplies across multiple therapeutic domains, including specialty pharmaceuticals, generic drugs, vaccines, and medical devices. The company's demonstrated capability to meet federal procurement standards through competitive award processes and its extensive experience supplying critical medications to Defense Health Agency and military service members positions it as a key vendor within the DLA's global pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.4k | 6/2/25 |